Côd QR

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss

Abstract Myelodysplastic neoplasms (MDSs) are clonal disorders characterized by ineffective hematopoiesis, dysplasia, and a risk of transformation into acute myeloid leukemia. MDS is also associated with a higher incidence of osteoporosis, suggesting a complex interplay between hematopoiesis, the bo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Manja Wobus, Heike Weidner, Rebekka Wehner, Anna‐Lena Baumann, Kristin Möbus, Ekaterina Balaian, Marie Törngren, Erik Vahtola, Helena Eriksson, Susann Winter, Uwe Platzbecker, Triantafyllos Chavakis, Lorenz Christian Hofbauer, Martina Rauner, Martin Bornhäuser, Katja Sockel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley 2026-04-01
Cyfres:HemaSphere
Mynediad Ar-lein:https://doi.org/10.1002/hem3.70352
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!